From: Downregulation of miR-451 in cholangiocarcinoma help the diagnsosi and promotes tumor progression
 | Total (n = 159) | miR-451 in tissues | P value | Total (n = 159) | miR-451 in serum | P value | ||
---|---|---|---|---|---|---|---|---|
 | Low (n = 83) | High (n = 76) | Low (n = 82) | High (n = 77) | ||||
Age | Â | Â | Â | 0.566 | Â | Â | Â | 0.593 |
 < 60 | 82 | 41 | 41 | 84 | 45 | 39 | ||
 ≥ 60 | 77 | 42 | 35 | 75 | 37 | 38 | ||
Gender | Â | Â | Â | 0.883 | Â | Â | Â | 0.347 |
 Male | 89 | 46 | 43 | 91 | 44 | 47 | ||
 Female | 70 | 37 | 33 | 68 | 38 | 30 | ||
TNM stage | Â | Â | Â | 0.014 | Â | Â | Â | 0.022 |
 I-II | 95 | 42 | 53 | 97 | 43 | 54 | ||
 III-IV | 64 | 41 | 23 | 62 | 39 | 23 | ||
Differentiation | Â | Â | Â | 0.196 | Â | Â | Â | 0.262 |
 Well-moderate | 92 | 44 | 48 | 94 | 45 | 49 | ||
 Poor | 67 | 39 | 28 | 65 | 37 | 28 | ||
LNM | Â | Â | Â | 0.015 | Â | Â | Â | 0.042 |
 Negative | 104 | 47 | 57 | 103 | 47 | 56 | ||
 Positive | 55 | 36 | 19 | 56 | 35 | 21 | ||
location | Â | Â | Â | 0.297 | Â | Â | Â | 0.373 |
 Intrahepatic | 81 | 39 | 42 | 83 | 40 | 43 | ||
 Extrahepatic | 78 | 44 | 34 | 76 | 42 | 34 |